video Video: Sino Biological: the global leader in recombinant technology 24 June 2021 | By Sino Biological Inc. Sino Biological is an international reagent supplier and service provider. The company specialises in recombinant protein production and antibody development.
whitepaper Brochure: Viral research solutions 24 June 2021 | By PerkinElmer Solutions to help you understand viral diseases and translate your research findings into better treatments and vaccines.
news Prime Minister unveils plans to make UK scientific ‘superpower’ 21 June 2021 | By Victoria Rees (Drug Target Review) A National Science and Technology Council and Office for Science and Technology Strategy will be established to aid the UK's scientific industry.
article Drug Target Review Stem Cells ebook 2021 21 June 2021 | By Drug Target Review Included in this ebook are articles on stem cell-derived liver organoids and pluripotent cell-derived endothelial cells.
whitepaper Catalogue: Resources for COVID-19 and influenza vaccine development 18 June 2021 | By Sino Biological Inc. A panel of SARS-CoV-2 reagents (e.g. antigens, antibodies, and kits) and influenza antigens have been developed to support the development of vaccines.
news Stem cells may be key for new vaccines against COVID-19 17 June 2021 | By Victoria Rees (Drug Target Review) Scientists say COVID-19 may activate tuberculosis infection, but stem cell-mediated defence mechanisms could be targeted to develop vaccines.
news Reference genome comparison finds exome variant discrepancies 15 June 2021 | By Victoria Rees (Drug Target Review) Scientists have found differences in 206 genes between the GRCh38 (hg38) and GRCh37 (hg19) human reference genomes.
news Human cells can write RNA sequences into DNA, study shows 14 June 2021 | By Victoria Rees (Drug Target Review) For the first time, scientists have found evidence that polymerase theta can write RNA segments back into DNA.
news Researchers link SARS-CoV-2 PLpro to COVID-19 symptoms 10 June 2021 | By Victoria Rees (Drug Target Review) Researchers have shown that the SARS-CoV-2 PLpro cuts human proteins so could potentially cause a range of COVID-19 symptoms.
news New X-ray scanner analyses biopsies and drugs in minutes 10 June 2021 | By Victoria Rees (Drug Target Review) Researchers have created an X-ray scanning machine that shows the shape of an object and its molecular composition.
whitepaper Brochure: Neuroscience solutions 9 June 2021 | By PerkinElmer Complete solutions for neurological disease research and discovery - helping you to better understand diseases to improve patient outcomes.
news SARS-CoV-2 “Mexican variant” sequence analysed by researchers 7 June 2021 | By Victoria Rees (Drug Target Review) Analysis of one million SARS-CoV-2 genome sequences has revealed a new variant named T478K, spreading mostly in Mexico.
whitepaper ebook: How automation makes labs more efficient 4 June 2021 | By SPT Labtech We discuss how liquid handling automation supports drug discovery workflows & highlight opportunities to improve the efficiency and quality of these.
news RT-ddPCR assay developed to quantify regions of SARS-CoV-2 RNA 2 June 2021 | By Victoria Rees (Drug Target Review) Scientists have created a RT-ddPCR assay to analyse both the non-coding and coding RNA regions of SARS-CoV-2.
whitepaper Application note: Western blot & IP assay to verify antibody specificity 1 June 2021 | By Bethyl Laboratories Learn about a practical, high-throughput method for validating the target-specificity of antibodies for the application of western blot.
